CAM
Cresset Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
10,644
+17
| +0.2% | +$2.15K | 0.01% | 681 |
|
|
2025
Q1 | $1.36M | Sell |
10,627
-734
| -6% | -$93.9K | 0.01% | 653 |
|
|
2024
Q4 | $1.5M | Sell |
11,361
-5,994
| -35% | -$792K | 0.01% | 624 |
|
|
2024
Q3 | $2.53M | Sell |
17,355
-1,851
| -10% | -$270K | 0.01% | 671 |
|
|
2024
Q2 | $2.64M | Buy |
19,206
+3,426
| +22% | +$470K | 0.01% | 591 |
|
|
2024
Q1 | $2.17M | Buy |
15,780
+169
| +1% | +$23.2K | 0.01% | 600 |
|
|
2023
Q4 | $2.12M | Sell |
15,611
-953
| -6% | -$129K | 0.01% | 553 |
|
|
2023
Q3 | $2.03M | Sell |
16,564
-1,010
| -6% | -$124K | 0.01% | 526 |
|
|
2023
Q2 | $2.23M | Buy |
17,574
+7,711
| +78% | +$979K | ﹤0.01% | 490 |
|
|
2023
Q1 | $1.27M | Buy |
9,863
+3,136
| +47% | +$405K | 0.03% | 297 |
|
|
2022
Q4 | $574K | Sell |
6,727
-419
| -6% | -$35.7K | 0.01% | 402 |
|
|
2022
Q3 | $837K | Buy |
7,146
+407
| +6% | +$47.7K | 0.01% | 391 |
|
|
2022
Q2 | $793K | Buy |
6,739
+3,547
| +111% | +$417K | 0.01% | 427 |
|
|
2022
Q1 | $416K | Sell |
3,192
-965
| -23% | -$126K | ﹤0.01% | 663 |
|
|
2021
Q4 | $634K | Buy |
4,157
+2,698
| +185% | +$411K | 0.01% | 616 |
|
|
2021
Q3 | $236K | Buy |
1,459
+150
| +11% | +$24.3K | ﹤0.01% | 955 |
|
|
2021
Q2 | $214K | Sell |
1,309
-1,149
| -47% | -$188K | ﹤0.01% | 924 |
|
|
2021
Q1 | $370K | Buy |
2,458
+235
| +11% | +$35.4K | 0.01% | 581 |
|
|
2020
Q4 | $337K | Buy |
2,223
+455
| +26% | +$69K | 0.01% | 521 |
|
|
2020
Q3 | $240K | Buy |
+1,768
| New | +$240K | ﹤0.01% | 579 |
|
|
2019
Q2 | – | Sell |
-226
| Closed | -$25K | – | 1014 |
|
|
2019
Q1 | $25K | Buy |
226
+76
| +51% | +$8.41K | ﹤0.01% | 957 |
|
|
2018
Q4 | $14K | Buy |
+150
| New | +$14K | ﹤0.01% | 785 |
|